Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility

BMC Genomics

Volumn 9, Issue , 2008, Pages

  Solé, Xavier ^a   Hernández, Pilar ^a   de Heredia, Miguel López ^b,c   Armengol, Lluís ^d   Rodríguez Santiago, Benjamín ^c,e   Gómez, Laia ^a   Maxwell, Christopher A ^a   Aguiló, Fernando ^f   Condom, Enric ^f   Abril, Jesús ^b   Pérez Jurado, Luis ^c,e,g   Estivill, Xavier ^d   Nunes, Virginia ^b,c,h   Capellá, Gabriel ^a   Gruber, Stephen B ⁱ   Moreno, Víctor ^a   Pujana, Miguel Angel ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 6; MYC PROTEIN; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN; KLF6 PROTEIN, HUMAN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL IMMORTALIZATION; CELL TRANSFORMATION; CHROMOSOME 8Q; COLORECTAL CANCER; CORRELATION ANALYSIS; DOWN REGULATION; FEEDBACK SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERM LINE; HAPLOTYPE MAP; HUMAN; LYMPHOCYTE; MALE; PHENOTYPE; PREDICTION; PROSTATE CANCER; QUANTITATIVE ANALYSIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GERM CELL; METABOLISM; ONCOGENE MYC; PROSTATE TUMOR; RISK FACTOR;

DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENETIC PREDISPOSITION TO DISEASE; GERM CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOCYTES; MALE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RISK FACTORS;

EID: 39149134006     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-9-12     Document Type: Article

References (70)

1. Freedman ML Haiman CA Patterson N McDonald GJ Tandon A Waliszewska A Penney K Steen RG Ardlie K John EM Oakley-Girvan I Whittemore AS Cooney KA Ingles SA Altshuler D Henderson BE Reich D Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men Proc Natl Acad Sci U S A 2006, 103(38):14068-14073. 1599913 16945910 10.1073/pnas.0605832103
2. Amundadottir LT Sulem P Gudmundsson J Helgason A Baker A Agnarsson BA Sigurdsson A Benediktsdottir KR Cazier JB Sainz J Jakobsdottir M Kostic J Magnusdottir DN Ghosh S Agnarsson K Birgisdottir B Le Roux L Olafsdottir A Blondal T Andresdottir M Gretarsdottir OS Bergthorsson JT Gudbjartsson D Gylfason A Thorleifsson G Manolescu A Kristjansson K Geirsson G Isaksson H Douglas J Johansson JE Balter K Wiklund F Montie JE Yu X Suarez BK Ober C Cooney KA Gronberg H Catalona WJ Einarsson GV Barkardottir RB Gulcher JR Kong A Thorsteinsdottir U Stefansson K A common variant associated with prostate cancer in European and African populations Nat Genet 2006, 38(6):652-658. 10.1038/ng1808 16682969
3. Suuriniemi M Agalliu I Schaid DJ Johanneson B McDonnell SK Iwasaki L Stanford JL Ostrander EA Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24 Cancer Epidemiol Biomarkers Prev 2007, 16(4):809-814. 10.1158/1055-9965.EPI-06-1049 17416775
4. Wang L McDonnell SK Slusser JP Hebbring SJ Cunningham JM Jacobsen SJ Cerhan JR Blute ML Schaid DJ Thibodeau SN Two common chromosome 8q24 variants are associated with increased risk for prostate cancer Cancer Res 2007, 67(7):2944-2950. 10.1158/0008-5472.CAN-06-3186 17409399
5. Schumacher FR Feigelson HS Cox DG Haiman CA Albanes D Buring J Calle EE Chanock SJ Colditz GA Diver WR Dunning AM Freedman ML Gaziano JM Giovannucci E Hankinson SE Hayes RB Henderson BE Hoover RN Kaaks R Key T Kolonel LN Kraft P Le Marchand L Ma J Pike MC Riboli E Stampfer MJ Stram DO Thomas G Thun MJ Travis R Virtamo J Andriole G Gelmann E Willett WC Hunter DJ A common 8q24 variant in prostate and breast cancer from a large nested case-control study Cancer Res 2007, 67(7):2951-2956. 10.1158/0008-5472.CAN-06-3591 17409400
6. Gudmundsson J Sulem P Manolescu A Amundadottir LT Gudbjartsson D Helgason A Rafnar T Bergthorsson JT Agnarsson BA Baker A Sigurdsson A Benediktsdottir KR Jakobsdottir M Xu J Blondal T Kostic J Sun J Ghosh S Stacey SN Mouy M Saemundsdottir J Backman VM Kristjansson K Tres A Partin AW Albers-Akkers MT Godino-Ivan Marcos J Walsh PC Swinkels DW Navarrete S Isaacs SD Aben KK Graif T Cashy J Ruiz-Echarri M Wiley KE Suarez BK Witjes JA Frigge M Ober C Jonsson E Einarsson GV Mayordomo JI Kiemeney LA Isaacs WB Catalona WJ Barkardottir RB Gulcher JR Thorsteinsdottir U Kong A Stefansson K Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 Nat Genet 2007, 39(5):631-637. 10.1038/ng1999 17401366
7. Haiman CA Patterson N Freedman ML Myers SR Pike MC Waliszewska A Neubauer J Tandon A Schirmer C McDonald GJ Greenway SC Stram DO Le Marchand L Kolonel LN Frasco M Wong D Pooler LC Ardlie K Oakley-Girvan I Whittemore AS Cooney KA John EM Ingles SA Altshuler D Henderson BE Reich D Multiple regions within 8q24 independently affect risk for prostate cancer Nat Genet 2007, 39(5):638-644. 10.1038/ng2015 17401364
8. Yeager M Orr N Hayes RB Jacobs KB Kraft P Wacholder S Minichiello MJ Fearnhead P Yu K Chatterjee N Wang Z Welch R Staats BJ Calle EE Feigelson HS Thun MJ Rodriguez C Albanes D Virtamo J Weinstein S Schumacher FR Giovannucci E Willett WC Cancel-Tassin G Cussenot O Valeri A Andriole GL Gelmann EP Tucker M Gerhard DS Fraumeni JF Jr. Hoover R Hunter DJ Chanock SJ Thomas G Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 Nat Genet 2007, 39(5):645-649. 10.1038/ng2022 17401363
9. Easton DF Pooley KA Dunning AM Pharoah PDP Thompson D Ballinger DG Struewing JP Morrison J Field H Luben R Wareham N Ahmed S Healey CS Bowman R Meyer KB Haiman CA Kolonel LK Henderson BE Le Marchand L Brennan P Sangrajrang S Gaborieau V Odefrey F Shen CY Wu PE Wang HC Eccles D Evans DG Peto J Fletcher O Johnson N Seal S Stratton MR Rahman N Chenevix-Trench G Bojesen SE Nordestgaard BG Axelsson CK Garcia-Closas M Brinton L Chanock S Lissowska J Peplonska B Nevanlinna H Fagerholm R Eerola H Kang D Yoo KY Noh DY Ahn SH Hunter DJ Hankinson SE Cox DG Hall P Wedren S Liu J Low YL Bogdanova N Schurmann P Dork T Tollenaar RAEM Jacobi CE Devilee P Klijn JGM Sigurdson AJ Doody MM Alexander BH Zhang J Cox A Brock IW MacPherson G Reed MWR Couch FJ Goode EL Olson JE Meijers-Heijboer H van den Ouweland A Uitterlinden A Rivadeneira F Milne RL Ribas G Gonzalez-Neira A Benitez J Hopper JL McCredie M Southey M Giles GG Schroen C Justenhoven C Brauch H Hamann U Ko YD Spurdle AB Beesley J Chen X Mannermaa A Kosma VM Kataja V Hartikainen J et al. Genome-wide association study identifies novel breast cancer susceptibility loci Nature 2007, 447:7148-1087. 1093 10.1038/ nature05887 17529967
10. Tomlinson I Webb E Carvajal-Carmona L Broderick P Kemp Z Spain S Penegar S Chandler I Gorman M Wood W Barclay E Lubbe S Martin L Sellick G Jaeger E Hubner R Wild R Rowan A Fielding S Howarth K Silver A Atkin W Muir K Logan R Kerr D Johnstone E Sieber O Gray R Thomas H Peto J Cazier JB Houlston R A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 Nat Genet 2007, 39:984-988. 10.1038/ng2085 17618284
11. Zanke BW Greenwood CMT Rangrej J Kustra R Tenesa A Farrington SM Prendergast J Olschwang S Chiang T Crowdy E Ferretti V Laflamme P Sundararajan S Roumy S Olivier JF Robidoux F Sladek R Montpetit A Campbell P Bezieau S O'Shea AM Zogopoulos G Cotterchio M Newcomb P McLaughlin J Younghusband B Green R Green J Porteous MEM Campbell H Blanche H Sahbatou M Tubacher E Bonaiti-Pellie C Buecher B Riboli E Kury S Chanock SJ Potter J Thomas G Gallinger S Hudson TJ Dunlop MG Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 Nat Genet 2007, 39:989-994. 10.1038/ng2089 17618283
12. Haiman CA Le Marchand L Yamamato J Stram DO Sheng X Kolonel LN Wu AH Reich D Henderson BE A common genetic risk factor for colorectal and prostate cancer Nat Genet 2007, 39:954-956. 10.1038/ng2098 17618282
13. Gruber SB Moreno V Rozek LS Rennert HS Lejbkowicz F Bonner JD Greenson JK Giordano TJ Fearon ER Rennert G Genetic Variation in 8q24 Associated with Risk of Colorectal Cancer Cancer Biol Ther 2007, 6:7. 17630503
14. Sato K Qian J Slezak JM Lieber MM Bostwick DG Bergstralh EJ Jenkins RB Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma J Natl Cancer Inst 1999, 91(18):1574-1580. 10.1093/jnci/91.18.1574 10491435
15. Williams K Fernandez S Stien X Ishii K Love HD Lau YF Roberts RL Hayward SW Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype Prostate 2005, 63(4):369-384. 10.1002/pros.20200 15937962
16. Ellwood-Yen K Graeber TG Wongvipat J Iruela-Arispe ML Zhang J Matusik R Thomas GV Sawyers CL Myc-driven murine prostate cancer shares molecular features with human prostate tumors Cancer Cell 2003, 4(3):223-238. 10.1016/S1535-6108(03)00197-1 14522256
17. Gil J Kerai P Lleonart M Bernard D Cigudosa JC Peters G Carnero A Beach D Immortalization of primary human prostate epithelial cells by c-Myc Cancer Res 2005, 65(6):2179-2185. 10.1158/0008-5472.CAN-03-4030 15781629
18. Gomez-Zaera M Abril J Gonzalez L Aguilo F Condom E Nadal M Nunes V Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients Mutat Res 2006, 595(1-2):42-51. 16472830
19. Nadal M Pera G Pujadas J Abril J Gonzalez L Aguilo F Condom E Gomez-Zaera M Nunes V Aneuploidy of chromosome Y in prostate tumors and seminal vesicles: A possible sign of aging rather than an indicator of carcinogenesis? Mol Carcinog 2007, 46(7):543-552. 10.1002/mc.20301 17295237
20. Linja MJ Savinainen KJ Saramaki OR Tammela TL Vessella RL Visakorpi T Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer Cancer Res 2001, 61(9):3550-3555. 11325816
21. Savinainen KJ Linja MJ Saramaki OR Tammela TL Chang GT Brinkmann AO Visakorpi T Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer Br J Cancer 2004, 90(5):1041-1046. 10.1038/sj.bjc.6601648 14997205
22. Ohl F Jung M Xu C Stephan C Rabien A Burkhardt M Nitsche A Kristiansen G Loening SA Radonic A Jung K Gene expression studies in prostate cancer tissue: Which reference gene should be selected for normalization? J Mol Med 2005, 83(12):1014-1024. 10.1007/s00109-005-0703-z 16211407
23. Wong KK deLeeuw RJ Dosanjh NS Kimm LR Cheng Z Horsman DE MacAulay C Ng RT Brown CJ Eichler EE Lam WL A comprehensive analysis of common copy-number variations in the human genome Am J Hum Genet 2007, 80(1):91-104. 1785303 17160897 10.1086/510560
24. Severi G Hayes VM Padilla EJ English DR Southey MC Sutherland RL Hopper JL Giles GG The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: Results from an Australian population-based case-control study Cancer Epidemiol Biomarkers Prev 2007, 16(3):610-612. 10.1158/ 1055-9965.EPI-06-0872 17372260
25. Tomlins SA Mehra R Rhodes DR Cao X Wang L Dhanasekaran SM Kalyana-Sundaram S Wei JT Rubin MA Pienta KJ Shah RB Chinnaiyan AM Integrative molecular concept modeling of prostate cancer progression Nat Genet 2007, 39(1):41-51. 10.1038/ng1935 17173048
26. Buttyan R Sawczuk IS Benson MC Siegal JD Olsson CA Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers Prostate 1987, 11(4):327-337. 10.1002/pros.2990110405 2446300
27. Fleming WH Hamel A MacDonald R Ramsey E Pettigrew NM Johnston B Dodd JG Matusik RJ Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia Cancer Res 1986, 46(3):1535-1538. 2417706
28. Futreal PA Coin L Marshall M Down T Hubbard T Wooster R Rahman N Stratton MR A census of human cancer genes Nat Rev Cancer 2004, 4(3):177-183. 10.1038/nrc1299 14993899
29. Zeller KI Jegga AG Aronow BJ O'Donnell KA Dang CV An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets Genome Biol 2003, 4(10):R69. 328458 14519204 10.1186/gb-2003-4-10-r69
30. Singh D Febbo PG Ross K Jackson DG Manola J Ladd C Tamayo P Renshaw AA D'Amico AV Richie JP Lander ES Loda M Kantoff PW Golub TR Sellers WR Gene expression correlates of clinical prostate cancer behavior Cancer Cell 2002, 1(2):203-209. 10.1016/S1535-6108(02)00030-2 12086878
31. Bodescot M Brison O Characterization of new human c-myc mRNA species produced by alternative splicing Gene 1996, 174(1):115-120. 10.1016/ 0378-1119(96)00464-7 8863737
32. Basso K Margolin AA Stolovitzky G Klein U Dalla-Favera R Califano A Reverse engineering of regulatory networks in human B cells Nat Genet 2005, 37(4):382-390. 10.1038/ng1532 15778709
33. Matys V Fricke E Geffers R Gossling E Haubrock M Hehl R Hornischer K Karas D Kel AE Kel-Margoulis OV Kloos DU Land S Lewicki-Potapov B Michael H Munch R Reuter I Rotert S Saxel H Scheer M Thiele S Wingender E TRANSFAC: Transcriptional regulation, from patterns to profiles Nucleic Acids Res 2003, 31(1):374-378. 165555 12520026 10.1093/nar/gkg108
34. Glinsky GV Glinskii AB Stephenson AJ Hoffman RM Gerald WL Gene expression profiling predicts clinical outcome of prostate cancer J Clin Invest 2004, 113(6):913-923. 362118 15067324 10.1172/JCI200420032
35. Bild AH Yao G Chang JT Wang Q Potti A Chasse D Joshi MB Harpole D Lancaster JM Berchuck A Olson JA Jr. Marks JR Dressman HK West M Nevins JR Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature 2006, 439(7074):353-357. 10.1038/nature04296 16273092
36. Huang E Ishida S Pittman J Dressman H Bild A Kloos M D'Amico M Pestell RG West M Nevins JR Gene expression phenotypic models that predict the activity of oncogenic pathways Nat Genet 2003, 34(2):226-230. 10.1038/ ng1167 12754511
37. DiFeo A Narla G Camacho-Vanegas O Nishio H Rose SL Buller RE Friedman SL Walsh MJ Martignetti JA E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor Oncogene 2006, 25(44):6026-6031. 10.1038/ sj.onc.1209611 16702959
38. Narla G Kremer-Tal S Matsumoto N Zhao X Yao S Kelley K Tarocchi M Friedman SL In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma Oncogene 2007, 26(30):4428-4434. 10.1038/sj.onc.1210223 17297474
39. Cheung VG Spielman RS The genetics of variation in gene expression Nat Genet 2002, 32(Suppl):522-525. 10.1038/ng1036 12454648
40. Buckland PR Allele-specific gene expression differences in humans Hum Mol Genet 2004, 13: Spec No 2 R255-60. 10.1093/hmg/ddh227 15358732
41. Spielman RS Bastone LA Burdick JT Morley M Ewens WJ Cheung VG Common genetic variants account for differences in gene expression among ethnic groups Nat Genet 2007, 39(2):226-231. 10.1038/ng1955 17206142
42. Stranger BE Forrest MS Dunning M Ingle CE Beazley C Thorne N Redon R Bird CP de Grassi A Lee C Tyler-Smith C Carter N Scherer SW Tavare S Deloukas P Hurles ME Dermitzakis ET Relative impact of nucleotide and copy number variation on gene expression phenotypes Science 2007, 315(5813):848-853. 10.1126/science.1136678 17289997
43. Mangues R Seidman I Gordon JW Pellicer A Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice Oncogene 1992, 7(10):2073-2076. 1328989
44. Sotillo R Hernando E Diaz-Rodriguez E Teruya-Feldstein J Cordon-Cardo C Lowe SW Benezra R Mad2 overexpression promotes aneuploidy and tumorigenesis in mice Cancer Cell 2007, 11(1):9-23. 1850996 17189715 10.1016/j.ccr.2006.10.019
45. Stewart TA Pattengale PK Leder P Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes Cell 1984, 38(3):627-637. 10.1016/0092-8674(84)90257-5 6488314
46. Leder A Pattengale PK Kuo A Stewart TA Leder P Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development Cell 1986, 45(4):485-495. 10.1016/ 0092-8674(86)90280-1 3011271
47. Chen Y Blackwell TW Chen J Gao J Lee AW States DJ Integration of genome and chromatin structure with gene expression profiles to predict c-MYC recognition site binding and function PLoS Comput Biol 2007, 3(4):e63. 1847699 17411336 10.1371/journal.pcbi.0030063
48. Bernard D Pourtier-Manzanedo A Gil J Beach DH Myc confers androgen-independent prostate cancer cell growth J Clin Invest 2003, 112(11):1724-1731. 281646 14660748 10.1172/JCI200319035
49. Margolin AA Nemenman I Basso K Wiggins C Stolovitzky G Dalla Favera R Califano A ARACNE: An algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context BMC Bioinformatics 2006, 7(Suppl 1):S7. 1810318 16723010 10.1186/1471-2105-7-S1-S7
50. Margolin AA Wang K Lim WK Kustagi M Nemenman I Califano A Reverse engineering cellular networks Nat Protoc 2006, 1(2):662-671. 10.1038/ nprot.2006.106 17406294
51. Narla G Heath KE Reeves HL Li D Giono LE Kimmelman AC Glucksman MJ Narla J Eng FJ Chan AM Ferrari AC Martignetti JA Friedman SL KLF6, a candidate tumor suppressor gene mutated in prostate cancer Science 2001, 294:5551-2563. 2566 10.1126/science.1066326 11752579
52. Yamashita K Upadhyay S Osada M Hoque MO Xiao Y Mori M Sato F Meltzer SJ Sidransky D Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma Cancer Cell 2002, 2(6):485-495. 10.1016/S1535-6108(02)00215-5 12498717
53. Jeng YM Hsu HC KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas Int J Cancer 2003, 105(5):625-629. 10.1002/ijc.11123 12740910
54. Teixeira MS Camacho-Vanegas O Fernandez Y Narla G Difeo A Lee B Kalir T Friedman SL Schlecht NF Genden EM Urken M Brandwein-Gensler M Martignetti JA KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma Int J Cancer 2007, 121(9):1976-1983. 10.1002/ijc.22926 17621627
55. Kremer-Tal S Reeves HL Narla G Thung SN Schwartz M Difeo A Katz A Bruix J Bioulac-Sage P Martignetti JA Friedman SL Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma Hepatology 2004, 40(5):1047-1052. 10.1002/hep.20460 15486921
56. Ito G Uchiyama M Kondo M Mori S Usami N Maeda O Kawabe T Hasegawa Y Shimokata K Sekido Y Kruppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells Cancer Res 2004 64 11 3838 3843 10.1158/0008-5472.CAN-04-0185 15172991
57. DiFeo A Narla G Hirshfeld J Camacho-Vanegas O Narla J Rose SL Kalir T Yao S Levine A Birrer MJ Bonome T Friedman SL Buller RE Martignetti JA Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination Clin Cancer Res 2006, 12(12):3730-3739. 10.1158/1078-0432.CCR-06-0054 16778100
58. Reeves HL Narla G Ogunbiyi O Haq AI Katz A Benzeno S Hod E Harpaz N Goldberg S Tal-Kremer S Eng FJ Arthur MJ Martignetti JA Friedman SL Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer Gastroenterology 2004, 126(4):1090-1103. 10.1053/j.gastro.2004.01.005 15057748
59. Richmond PJ Karayiannakis AJ Nagafuchi A Kaisary AV Pignatelli M Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival Cancer Res 1997, 57(15):3189-3193. 9242448
60. Isaacs WB Bova GS Morton RA Bussemakers MJ Brooks JD Ewing CM Molecular biology of prostate cancer progression Cancer Surv 1995, 23:19-32. 7621457
61. Cortina C Palomo-Ponce S Iglesias M Fernandez-Masip JL Vivancos A Whissell G Huma M Peiro N Gallego L Jonkheer S Davy A Lloreta J Sancho E Batlle E EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells Nat Genet 2007 17906625
62. He TC Sparks AB Rago C Hermeking H Zawel L da Costa LT Morin PJ Vogelstein B Kinzler KW Identification of c-MYC as a target of the APC pathway Science 1998, 281:5382-1509. 1512 10.1126/science.281.5382.1509 9727977
63. Witte JS Multiple prostate cancer risk variants on 8q24 Nat Genet 2007, 39(5):579-580. 10.1038/ng0507-579 17460686
64. D'Cruz CM Gunther EJ Boxer RB Hartman JL Sintasath L Moody SE Cox JD Ha SI Belka GK Golant A Cardiff RD Chodosh LA c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations Nat Med 2001, 7(2):235-239. 10.1038/84691 11175856
65. van de Wetering M Sancho E Verweij C de Lau W Oving I Hurlstone A van der Horn K Batlle E Coudreuse D Haramis AP Tjon-Pon-Fong M Moerer P van den Born M Soete G Pals S Eilers M Medema R Clevers H The beta-catenin/ TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells Cell 2002, 111(2):241-250. 10.1016/S0092-8674(02)01014-0 12408868
66. Mukai S Hiyama T Tanaka S Yoshihara M Arihiro K Chayama K Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma World J Gastroenterol 2007, 13(29):3932-3938. 17663506
67. Miyaki M Yamaguchi T Iijima T Funata N Mori T Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients Oncology 2006M 71(1-2):131-135. 10.1159/000100523 17347589
68. Gonzalez JR Armengol L Sole X Guino E Mercader JM Estivill X Moreno V SNPassoc: An R package to perform whole genome association studies Bioinformatics 2007, 23(5):644-645. 10.1093/bioinformatics/btm025 17267436
69. Sole X Guino E Valls J Iniesta R Moreno V SNPStats: A web tool for the analysis of association studies Bioinformatics 2006, 22(15):1928-1929. 10.1093/bioinformatics/btl268 16720584
70. Barrett JC Fry B Maller J Daly MJ Haploview: Analysis and visualization of LD and haplotype maps Bioinformatics 2005, 21(2):263-265. 10.1093/ bioinformatics/bth457 15297300